Genetically engineered strain and method for improving yield and conversion rate of uridine and application of genetically engineered strain

By knocking out arcA and replacing the pgi promoter in the genetically engineered strain E.coli UR11, E.coli UR13 was constructed, and the uridine synthesis path was modified using CRISPR/Cas9 technology, the problem of insufficient uridine yield and conversion rate was solved, and the problem of insufficient uridine production and conversion rate was achieved. Significant improvement in uridine production and conversion rate.

CN119081979APending Publication Date: 2024-12-06TIANJIN UNIV OF SCI & TECH
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411283314.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-13
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

There is still room for improvement in the yield and conversion rate of uridine in the prior art, especially in microbial fermentation methods. Although the cost is low and environmentally friendly, the yield and conversion rate are not sufficient to meet market demand.

Method used

Genetically engineered strain E.coli was constructed by knocking out the global transcription regulator encoding gene arcA in the genetically engineered strain E.coli UR11 and replacing the promoter Ppgi, which encodes gene pgi by glucose isomerase-encoding gene pgi using the uracil-responsive promoter PpyrB. UR13 is modified using CRISPR/Cas9-mediated gene editing technology to dynamically regulate the uridine synthesis pathway to improve the yield and conversion of uridine.

Benefits of technology

The yield and conversion rate of uridine were significantly improved. The yield of fermented uridine in shake flask increased from 8g/L to 11g/L, an increase of 37.5%. The uridine production in fermentation tanks increased from 40g/L to 52g/L, an increase of 30%. , the glycoside conversion rate increased from 15% to 20%, an increase of 33%.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119081979A_ABST
    Figure CN119081979A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of gene engineering, and discloses a gene engineering strain capable of improving yield and conversion rate of uridine, the gene engineering strain is obtained by deleting a global transcriptional regulatory factor coding gene arcA on the basis of a gene engineering strain E.coli UR11 (CN108130306B) for producing uridine, and the gene engineering strain can be used for producing uridine. And a uracil response type promoter PpyrB is used for replacing a promoter Ppgi of a phosphoglucose isomerase coding gene pgi, so that the genetically engineered bacterium E.coli UR13 is constructed. By means of the metabolic transformation, the metabolic efficiency of TCA circulation can be improved, the metabolic flux of a pentose phosphate pathway can be dynamically adjusted, more precursors glutamine, aspartic acid and PRPP are provided for uridine synthesis, and then the yield and conversion rate of uridine fermentation are improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of genetic engineering, and in particular to a genetic engineering strain, method and application for improving uridine production and conversion rate. Background Art

[0002] Uridine, also known as 1-β-D-furanosyl uracil, is an important pyrimidine nucleoside in organisms. Uridine is widely used in food, health products and cosmetics. It can be added to milk powder as a food flavoring and nutritional enhancer to improve infant immunity, and can also be used as an intermediate in the synthesis of nucleoside drugs such as fluorouracil. With the continuous development and research of uridine functions, the market demand for uridine is also increasing rapidly. Therefore, a production process technology that can achieve large-scale production, high efficiency and cost-effectiveness is needed.

[0003] At present, uridine can be obtained by RNA hydrolysis, chemical synthesis and microbial fermentation. Although the RNA hydrolysis method has a simple process, it requires a large amount of high-quality RNA raw materials, the product separation is difficult, and the product purity is low. Chemical synthesis is the main industrial production method, but a large amount of toxic reagents need to be used in the synthesis process, which is environmentally unfriendly, the product yield is low, and the reaction conditions are harsh. In comparison, the microbial fermentation method has low production cost, environmental friendliness, high yield, and easy control, which can effectively improve the economic efficiency of industrial large-scale production.

[0004] Chinese patent publication CN 108130306 B provides a genetic engineering bacterium with high uridine production, and a construction method and application thereof. The bacterium integrates the pyrimidine nucleoside operon pyrBCAKDFE into the genome of Escherichia coli, and is started by the strong promoter Ptrc, thereby reconstructing the uridine synthesis pathway; a double copy of its own PRPP synthase encoding gene prsA is made on the genome, and is started by the strong promoter Ptrc; the activities of uridine kinase (udk), uridine phosphorylase (udp) and nucleoside hydrolase (rihA, rihB and rihC) are simultaneously missing; the activity of homoserine dehydrogenase 1 (thrA) is missing; and the activity of ornithine carbamoyltransferase (argF) is missing. The genetic engineering bacterium is applied to the fermentation production of uridine, and 40 g / L of uridine can be produced in a 5L fermenter for 40 hours, and the glycoside conversion rate is 15%.

[0005] Therefore, although the fermentation production of uridine has been achieved in the prior art, there is still much room for improvement in yield and conversion rate. Summary of the invention

[0006] The purpose of the present invention is to overcome the deficiencies in the prior art and provide a genetically engineered strain, method and application for increasing uridine production and conversion rate.

[0007] The technical solution adopted by the present invention to solve its technical problem is:

[0008] A genetically engineered strain for improving uridine production and conversion rate, wherein the genetically engineered strain is based on a genetically engineered bacterium E.coli UR11 (CN 108130306 B) for producing uridine, the global transcriptional regulator encoding gene arcA is deleted, and a uracil-responsive promoter P is used. pyrB Replace the promoter of the gene encoding phosphoglucose isomerase pgi pgi , the genetically engineered bacteria E. coli UR13 was constructed.

[0009] Furthermore, the gene sequence of the global transcriptional regulator encoding gene arcA is SEQ ID NO.1, and the uracil-responsive promoter P pyrB The gene sequence is SEQ ID NO.2, and the promoter P of the phosphoglucose isomerase encoding gene pgi pgi The gene sequence is SEQ ID NO.17.

[0010] The method for constructing the genetically engineered strain as described above is to gradually transform E. coli UR11 using CRISPR / Cas9-mediated gene editing technology, and the steps are as follows:

[0011] (1) Knockout of arcA, the gene encoding the global transcriptional regulator;

[0012] (2) Using uracil-responsive promoter P pyrB Replace the promoter of the gene encoding phosphoglucose isomerase pgi pgi ;

[0013] The CRISPR / Cas9-mediated gene editing technology includes constructing a recombinant fragment and a pGRB plasmid, simultaneously transforming the pGRB plasmid and the recombinant fragment into electroporated cells containing pREDCas9, and performing a plasmid elimination step to obtain a recombinant genetic engineering strain.

[0014] Furthermore, the construction of the pGRB plasmid includes: designing a target sequence, preparing a DNA fragment containing the target sequence, and recombining the DNA fragment containing the target sequence with a linearized vector fragment; preferably, the target sequence is 5'-NGG-3';

[0015] The construction of the recombinant fragment includes constructing a gene-integrated recombinant fragment or constructing a gene-knocked recombinant fragment; wherein the step of constructing the gene-integrated recombinant fragment includes: using the genome of the starting strain as a template, designing upstream and downstream homology arm primers according to the upstream and downstream sequences of the intended insertion site of the target gene, and designing primers according to the target genome, amplifying the target gene fragment, and then obtaining the recombinant fragment by PCR overlap technology.

[0016] The use of the genetically engineered strain as described above in the production of uridine.

[0017] The method for producing uridine by fermentation using the genetically engineered strain as described above comprises the following steps:

[0018] The genetically engineered strain is contacted with a fermentation medium to carry out fermentation culture to prepare uridine.

[0019] Furthermore, the fermentation culture is shake flask fermentation or fermentation tank fermentation;

[0020] During shake flask fermentation, the strain is activated to prepare seed liquid, which is inoculated into a 500 mL triangular flask filled with fermentation medium at an inoculation rate of 10-15%, sealed with nine layers of gauze, and cultured at 37°C and 220 r / min with shaking. During the fermentation process, ammonia water is added to maintain the pH at 7.0-7.2; a glucose solution with a mass concentration of 60% (m / v) is added to maintain the fermentation process; the fermentation cycle is 24 hours, and the product is obtained;

[0021] During fermentation in a fermenter, the strain is activated to prepare a seed solution, which is then inoculated with a fresh fermentation medium at a rate of 15-20% to start fermentation. During the fermentation process, the pH is controlled to be stable at 7.0-7.2, the temperature is maintained at 37°C, and the dissolved oxygen is between 25-35%. When the glucose in the medium is consumed, a glucose solution with a mass concentration of 80% (m / v) is added to maintain the glucose concentration in the fermentation medium at 0.1-5 g / L. The fermentation cycle is 40 hours to obtain the product.

[0022] Furthermore, the fermentation medium composition during shake flask fermentation is: glucose 20-40 g / L, (NH4)2SO4 1-3 g / L, KH2PO4 1-3 g / L, MgSO4·7H2O 1-2 g / L, yeast extract 0.1-0.3 g / L, corn steep liquor 1-2 mL / L, FeSO4·7H2O 80-100 mg / L, MnSO4·7H2O 80-100 mg / L, and the rest is water, with a pH of 7.0-7.2.

[0023] Further, the fermentation medium of the fermentation tank is composed of: glucose 15-25 g / L, yeast extract 1-5 g / L, tryptone 1-5 g / L, sodium citrate 0.1-1 g / L, KH2PO4 1-5 g / L, MgSO4·7H2O 0.1-1 g / L, FeSO4·7H2O 80-100 mg / L, MnSO4·7H2O 80-100 mg / L, V B1 、V B3 、V B5 、V B12 , V H0.5-2 mg / L each, 50-200 mg / L each of threonine, lysine, methionine, glutamine, and arginine, two drops of defoaming agent, and the rest is water, pH is 7.0-7.2.

[0024] Furthermore, after 24h of shake flask fermentation, the uridine production in the fermentation broth of E. coli UR13 strain increased from 8g / L to 11g / L, an increase of 37.5% compared with the original strain E. coli UR11.

[0025] After 40 hours of fermentation in the fermenter, compared with the original strain E. coli UR11, the uridine production in the fermentation broth of E. coli UR13 strain increased from 40 g / L to 52 g / L, an increase of 30%, and the glycoside conversion rate increased from 15% to 20%, an increase of 33%.

[0026] The advantages and positive effects achieved by the present invention are:

[0027] 1. The present invention can improve the metabolic efficiency of TCA by knocking out the global transcription factor arcA, providing more precursors glutamine and aspartic acid for uridine synthesis, thereby improving the efficiency of uridine synthesis.

[0028] 2. Escherichia coli phosphoglucose isomerase is an important node in determining the metabolic diversion between glycolysis and the pentose phosphate pathway. pyrB The expression of the gene encoding phosphoglucose isomerase, pgi, can be dynamically regulated. When the intracellular uracil concentration is low, the expression of pgi is low and the metabolic flux of glycolysis is high; when the uracil concentration is high, the expression of pgi is high and the metabolic flux of the pentose phosphate pathway is high. Uracil is a byproduct of uridine fermentation and increases with the accumulation of uridine. Therefore, through this dynamic regulation strategy, more precursor PRPP can be provided for uridine synthesis during the uridine accumulation period, thereby improving the efficiency of uridine synthesis.

[0029] 3. After 24h of shake flask fermentation, the uridine yield in the fermentation broth of the E. coli UR13 strain increased from 8 g / L to 11 g / L, an increase of 37.5%, compared with the original strain E. coli UR11.

[0030] After fermentation for 40 hours in the fermenter, compared with the original strain E. coli UR11, the uridine yield in the fermentation liquid of the E. coli UR13 strain increased from 40 g / L to 52 g / L, an increase of 30%, and the glycoside conversion rate increased from 15% to 20%, an increase of 33%. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1This is the electrophoresis diagram of arcA gene knockout fragment construction and verification in the present invention; wherein, M: 1kb DNA marker, 1: arcA upstream homology arm, 2: arcA downstream homology arm, 3: overlapping fragment, 4: original bacteria control, 5: positive bacteria identification fragment;

[0032] Figure 2 For the present invention, P pyrB Replace P pgi Promoter construction and verification electrophoresis diagram; where: M: 1kb DNA marker, 1: P pyrB Upstream homology arm fragment, 2:P pyrB Downstream homology arm fragment, 3:P pyrB Target gene fragment, 4:P pyrB Overlapping fragments, 5: original bacteria control identification results, 6: positive bacteria identification fragments;

[0033] Figure 3 This is a comparison chart of the results of uridine fermentation by the strain E. coli UR13 in the present invention;

[0034] Figure 4 This is a comparison chart of the results of uridine fermentation in a fermenter using the strain E. coli UR13 of the present invention. DETAILED DESCRIPTION

[0035] The present invention will be further described below in conjunction with the embodiments. The following embodiments are descriptive rather than restrictive, and the protection scope of the present invention cannot be limited by the following embodiments.

[0036] The various experimental operations involved in the specific embodiments are all routine techniques in the art. For parts not specially annotated in this document, ordinary technicians in the art can implement them by referring to various commonly used reference books, scientific and technological literature or related instructions, manuals, etc. before the filing date of this invention.

[0037] A genetically engineered strain for improving uridine production and conversion rate, wherein the genetically engineered strain is based on a genetically engineered bacterium E.coli UR11 (CN 108130306 B) for producing uridine, the global transcriptional regulator encoding gene arcA is deleted, and a uracil-responsive promoter P is used. pyrB Replace the promoter of the gene encoding phosphoglucose isomerase pgi pgi , the genetically engineered bacteria E. coli UR13 was constructed.

[0038] Preferably, the gene sequence of the global transcriptional regulator encoding gene arcA is SEQ ID NO.1, and the uracil-responsive promoter P pyrB The gene sequence is SEQ ID NO.2, and the promoter P of the phosphoglucose isomerase encoding gene pgipgi The gene sequence is SEQ ID NO.17.

[0039] The method for constructing the genetically engineered strain as described above is to gradually transform E. coli UR11 using CRISPR / Cas9-mediated gene editing technology, and the steps are as follows:

[0040] (1) Knockout of arcA, the gene encoding the global transcriptional regulator;

[0041] (2) Using uracil-responsive promoter P pyrB Replace the promoter of the gene encoding phosphoglucose isomerase pgi pgi ;

[0042] The CRISPR / Cas9-mediated gene editing technology includes constructing a recombinant fragment and a pGRB plasmid, simultaneously transforming the pGRB plasmid and the recombinant fragment into electroporated cells containing pREDCas9, and performing a plasmid elimination step to obtain a recombinant genetic engineering strain.

[0043] Preferably, the construction of the pGRB plasmid includes: designing a target sequence, preparing a DNA fragment containing the target sequence, and recombining the DNA fragment containing the target sequence with a linearized vector fragment; preferably, the target sequence is 5'-NGG-3';

[0044] The construction of the recombinant fragment includes constructing a gene-integrated recombinant fragment or constructing a gene-knocked recombinant fragment; wherein the step of constructing the gene-integrated recombinant fragment includes: using the genome of the starting strain as a template, designing upstream and downstream homology arm primers according to the upstream and downstream sequences of the intended insertion site of the target gene, and designing primers according to the target genome, amplifying the target gene fragment, and then obtaining the recombinant fragment by PCR overlap technology.

[0045] The use of the genetically engineered strain as described above in the production of uridine.

[0046] The method for producing uridine by fermentation using the genetically engineered strain as described above comprises the following steps:

[0047] The genetically engineered strain is contacted with a fermentation medium to carry out fermentation culture to prepare uridine.

[0048] Preferably, the fermentation culture is shake flask fermentation or fermentation tank fermentation;

[0049] During shake flask fermentation, the strain is activated to prepare seed liquid, which is inoculated into a 500 mL triangular flask filled with fermentation medium at an inoculation rate of 10-15%, sealed with nine layers of gauze, and cultured at 37°C and 220 r / min with shaking. During the fermentation process, ammonia water is added to maintain the pH at 7.0-7.2; a glucose solution with a mass concentration of 60% (m / v) is added to maintain the fermentation process; the fermentation cycle is 24 hours, and the product is obtained;

[0050] During fermentation in a fermenter, the strain is activated to prepare a seed solution, which is then inoculated with a fresh fermentation medium at a rate of 15-20% to start fermentation. During the fermentation process, the pH is controlled to be stable at 7.0-7.2, the temperature is maintained at 37°C, and the dissolved oxygen is between 25-35%. When the glucose in the medium is consumed, a glucose solution with a mass concentration of 80% (m / v) is added to maintain the glucose concentration in the fermentation medium at 0.1-5 g / L. The fermentation cycle is 40 hours to obtain the product.

[0051] Preferably, the fermentation medium composition during shake flask fermentation is: glucose 20-40 g / L, (NH4)2SO4 1-3 g / L, KH2PO4 1-3 g / L, MgSO4·7H2O 1-2 g / L, yeast extract 0.1-0.3 g / L, corn steep liquor 1-2 mL / L, FeSO4·7H2O 80-100 mg / L, MnSO4·7H2O 80-100 mg / L, and the rest is water, with a pH of 7.0-7.2.

[0052] Preferably, the fermentation medium for fermentation in the fermenter is composed of: glucose 15-25 g / L, yeast extract 1-5 g / L, tryptone 1-5 g / L, sodium citrate 0.1-1 g / L, KH2PO4 1-5 g / L, MgSO4·7H2O 0.1-1 g / L, FeSO4·7H2O 80-100 mg / L, MnSO4·7H2O 80-100 mg / L, V B1 、V B3 、V B5 、V B12 , V H 0.5-2 mg / L each, 50-200 mg / L each of threonine, lysine, methionine, glutamine, and arginine, two drops of defoaming agent, and the rest is water, pH is 7.0-7.2.

[0053] Preferably, after shake flask fermentation for 24 hours, the uridine yield in the fermentation broth of the E. coli UR13 strain increased from 8 g / L to 11 g / L, an increase of 37.5% compared with the original strain E. coli UR11;

[0054] After 40 hours of fermentation in the fermenter, compared with the original strain E. coli UR11, the uridine production in the fermentation broth of E. coli UR13 strain increased from 40 g / L to 52 g / L, an increase of 30%, and the glycoside conversion rate increased from 15% to 20%, an increase of 33%.

[0055] Specifically, the relevant preparation and detection are as follows:

[0056] The various experimental operations involved in the specific embodiments are all routine techniques in the art. For parts not specially annotated in this document, ordinary technicians in the art can implement them by referring to various commonly used reference books, scientific and technological literature or related instructions, manuals, etc. before the filing date of this invention.

[0057] 1. Gene Editing Methods

[0058] The present invention adopts a CRISPR / Cas9-mediated gene editing method, which can be carried out with reference to the literature (Metabolic Engineering, 2015, 31: 13-21.). CRISPR / Cas9 is a precise and efficient new gene targeting modification technology. The two plasmids used in this method are pGRB and pREDCas9. The pREDCas9 plasmid is a temperature-sensitive plasmid that carries a gRNA plasmid elimination system, a lambda phage Red recombination system, and a Cas9 protein expression system. It has spectinomycin resistance (working concentration: 100 mg / L) and an optimal culture temperature of 32°C. The pGRB plasmid uses pUC18 as a backbone, contains a promoter J23100, a gRNA-Cas9 binding region sequence, and a terminator sequence, and has ampicillin resistance (working concentration: 100 mg / L) and an optimal culture temperature of 37°C.

[0059] The specific steps of this method are as follows:

[0060] 1.1 Construction of pGRB plasmid

[0061] The purpose of constructing the plasmid pGRB is to transcribe the corresponding gRNA, thereby forming a complex with the Cas9 protein, and recognize the target gene target site through base pairing and PAM to achieve the target DNA double-strand break. The pGRB plasmid is constructed by recombination of a DNA fragment containing the target sequence with a linearized vector fragment.

[0062] 1.1.1 Target sequence design

[0063] The target sequence (PAM: 5'-NGG-3') was designed using CRISPRRGEN Tools as follows:

[0064] arcA target sequence: ATCAACAGCCGTTCGTTGAT

[0065] P pgi Target sequence: TACACTCAACATTACGCTAA

[0066] 1.1.2 Preparation of DNA fragments containing target sequences

[0067] Design primers: 5'-linearized vector end sequence (15bp)-restriction site-target sequence (excluding PAM sequence)-linearized vector end sequence (15bp)-3' and its reverse complementary primer (pGRB identification primer: pGRB-Test-S: GTCTCATGAGCGGATACATATTTG; pGRB-Test-A: ATGAGAAAGCGCCACGCT), prepare DNA fragments containing target sequences by annealing single-stranded DNA. Reaction conditions: pre-denaturation 95℃, 5min; annealing 50℃, 1min; incubation 4℃. The annealing system is as shown in Table 1:

[0068] Table 1 Annealing system

[0069]

[0070] 1.1.3 Preparation of linear vector

[0071] The vector was linearized by inverse PCR amplification.

[0072] 1.1.4 Recombination reaction

[0073] The recombination system is shown in Table 2. The recombinant enzymes used are all enzymes of the II One Step Cloning Kit series, and the recombination conditions are: 37°C, 30 min.

[0074] Table 2 Recombination system

[0075] Reaction system volume 5×CEⅡBuffer 4μL Linearized vector 54ng Insert 20ng ExnaseⅡ 2μL <![CDATA[ddH2O]]> Up to 20 μL

[0076] 1.1.5 Plasmid transformation

[0077] Take 20 μL of the above reaction solution, i.e. the liquid after plasmid recombination reaction, and add it to 100 mL DH5α transfection competent cells. Mix gently and place on ice for 20 minutes, heat shock at 42°C for 42 seconds, immediately place on ice for 2-3 minutes, add 900 μL SOC, and resuscitate at 37°C for 1 hour. Centrifuge at 8000 rpm for 2 minutes, discard part of the supernatant, keep about 200 μL, resuspend the bacteria and apply it to a plate containing 100 mg / L ampicillin, turn the plate upside down, and culture at 37°C overnight. After a single colony grows on the plate, identify it by colony PCR and select the positive recombinants.

[0078] 1.2 Preparation of recombinant DNA fragments

[0079] The recombinant fragment used for knockout is composed of the upstream and downstream homologous arms of the gene to be knocked out (upstream homologous arm-downstream homologous arm); the recombinant fragment used for integration is composed of the upstream and downstream homologous arms of the integration site and the gene fragment to be integrated (upstream homologous arm-target gene-downstream homologous arm). Using the primer design software Oligo 7, the upstream and downstream sequences of the gene to be knocked out or the site to be integrated are used as templates to design upstream and downstream homologous arm primers (amplification length is about 300-500bp); using the gene to be integrated as a template, design the amplification primers of the integrated gene. After amplifying the upstream and downstream homologous arms and the target gene fragments respectively by PCR, the recombinant fragments are prepared by overlapping PCR. The system and method of PCR are as shown in Table 3 below:

[0080] Table 3 PCR amplification system

[0081]

[0082] The system of overlapping PCR is shown in Table 4:

[0083] Table 4 Overlapping PCR amplification system

[0084]

[0085] PCR reaction conditions (Bao Ri Yisheng PrimeSTAR HSDNA Polymerase): pre-denaturation (95 ° C) for 5 min; denaturation (98 ° C) for 10 s, annealing (60 ° C) for 15 s, extension at 72 ° C, 30 cycles; further extension at 72 ° C for 10 min; insulation (4 ° C).

[0086] 1.3 Transformation of plasmids and recombinant DNA fragments

[0087] 1.3.1 Transformation with pREDCas9

[0088] The pREDCas9 plasmid was electroporated into the electroporation competent cells of W3110 by electroporation, and the cells were revived and cultured and then plated on LB plates containing 0.1% spectinomycin at a final concentration of 32°C overnight. Single colonies grown on the resistant plates were subjected to colony PCR using identification primers to screen for positive recombinants.

[0089] 1.3.2 Preparation of electroporation competent cells of target strains containing pREDCas9

[0090] Culture at 32°C until OD 600 When the OD was 0.1, IPTG was added to a final concentration of 0.1 mM and the culture was continued until the OD 600 When the pH is 0.2-0.3, competent cells are prepared. The purpose of adding IPTG is to induce the expression of the recombinase on the pREDCas9 plasmid. The culture medium and preparation process required for competent cells are referred to conventional standard operations.

[0091] 1.3.3 Transformation of pGRB and recombinant DNA fragments

[0092] pGRB and the recombinant DNA fragment were simultaneously electrotransformed into electrocompetent cells containing pREDCas9. The revived bacteria after electrotransformation were spread on LB plates containing 100 μg / mL ampicillin and spectinomycin and cultured overnight at 32°C. Colony PCR verification was performed using the upstream primer of the upstream homology arm and the downstream primer of the downstream homology arm, or specially designed identification primers, to screen positive recombinants and preserve the bacteria.

[0093] 1.4 Elimination of plasmid

[0094] 1.4.1 Elimination of pGRB

[0095] The positive recombinants were cultured overnight in LB medium containing 20 mmol / L arabinose, and then appropriately diluted and spread on LB plates containing 100 μg / mL spectinomycin resistance, and cultured overnight at 32°C. Single colonies were transferred to LB plates containing 100 μg / mL ampicillin and spectinomycin resistance, and single colonies that did not grow on ampicillin plates but grew on spectinomycin resistance plates were selected for preservation.

[0096] 1.4.2 Elimination of pREDCas9 plasmid

[0097] Transfer the positive recombinant to LB liquid medium without resistance, culture at 42℃ overnight, dilute appropriately and spread on LB plate without resistance, culture at 37℃ overnight. For LB plates containing spectinomycin resistance and LB plates without resistance, select single colonies that do not grow on spectinomycin resistance plates but grow on plates without resistance.

[0098] 2. Detailed process of E. coli UR13 strain construction

[0099] The present invention is based on a genetically engineered bacterium E.coli UR11 (CN 108130306 B) for producing uridine, in which the global transcriptional regulator encoding gene arcA is deleted and the uracil responsive promoter P is used. pyrB Replace the promoter of the gene encoding phosphoglucose isomerase pgi pgi , the genetically engineered bacteria E. coli UR13 was constructed.

[0100] 2.1 arcA gene knockout

[0101] According to the upstream and downstream sequences of the arcA gene, upstream homology arm primers UP-arcA-S (SEQ ID NO.3) and UP-arcA-A (SEQ ID NO.4) and downstream homology arm primers DN-arcA-S (SEQ ID NO.5) and DN-arcA-A (SEQ ID NO.6) were designed, and the genome of the strain E. coli W3110 was used as a template, and the upstream and downstream homology arms were amplified by PCR technology, and the knockout fragment of the gene (upstream homology arm-downstream homology arm) was obtained by the recombinant PCR method. A DNA fragment containing the target sequence of the target gene was obtained by annealing primers gRNA-arcA-S (SEQ ID NO.7) and gRNA-arcA-A (SEQ ID NO.8), and recombined with a linearized pGRB vector to obtain a recombinant pGRB-arcA. The integration fragment and pGRB-arcA were electroporated into E. coli UR11 competent cells containing pREDCas9 plasmid, and single colonies were obtained by resuscitation culture. Positive recombinants were obtained by PCR colony verification, and then pGRB-arcA used for gene editing was eliminated, that is, strain E. coli UR12. The verification picture is shown in the figure Figure 1 shown.

[0102] 2.2 Promoter replacement of pgi gene

[0103] According to the P pyrB and P pgi Sequence design of upstream homology arm primer Up-P pgi -S (SEQ ID NO.9), Up-P pgi -P pyrB -A (SEQ ID NO.10) and downstream homology arm primer Down-P pgi -P pyrB -S (SEQ ID NO.11), DN-P pgi -A (SEQ ID NO.12), using the genome of strain E. coli W3110 as a template, PCR technology was used to amplify the upstream and downstream homology arms, according to P pyrB Design primers P for target gene pgi -P pyrB -S (SEQ ID NO. 13), P pgi -P pyrB -A (SEQ ID NO.14), and amplify P pyrB The above fragments were obtained by overlapping PCR method. pyrB Replace the overlapping fragment of pgI promoter. pgi -S (SEQ ID NO.15) and gRNA-P pgi-A (SEQ ID NO.16) was annealed to obtain a DNA fragment containing the target sequence of the target gene, which was recombined with the linearized pGRB vector to obtain the recombinant pGRB-P pgi . The integration fragment and pGRB-P pgi The pREDCas9 plasmid was electrotransformed into E. coli UR12 competent cells, and single colonies were obtained by resuscitation culture. Positive recombinants were obtained by PCR colony verification, and then pGRB-P used for gene editing was eliminated. pgi , namely strain E. coli UR13. The verification diagram is provided by Figure 2 shown.

[0104] 3. Primers used in strain construction

[0105] All primers used in the strain construction process are shown in the table below:

[0106]

[0107] Example 2: Production of uridine by shaking flask fermentation using genetically engineered bacteria E. coli UR13:

[0108] Fermentation process: Take the -80℃ preserved strain and inoculate it on the activated slant, culture it at 37℃ for 12h, and pass it once. Use an inoculation loop to scrape a ring of slant seeds and inoculate it into a 500mL triangular flask containing 30mL seed culture medium, seal it with nine layers of gauze, and culture it at 37℃ and 220rpm for 10h. Inoculate it into a 500mL triangular flask containing fermentation medium (final volume is 30mL) according to the inoculation amount of 15% of the volume of the seed culture solution, seal it with nine layers of gauze, and culture it at 37℃ and 220r / min. During the fermentation process, add ammonia water to maintain the pH at 7.0-7.2; add 60% (m / v, mass concentration) glucose solution to maintain the fermentation; the fermentation cycle is 24h.

[0109] The slant culture medium was LB solid medium.

[0110] The composition of the seed culture medium is: glucose 30 g / L, (NH4)2SO4 3 g / L, KH2PO4 3 g / L, MgSO4·7H2O 2 g / L, yeast extract 6 g / L, FeSO4·7H2O 2 mg / L, MnSO4·7H2O 2 mg / L, and the rest is water, with a pH of 7.0-7.2.

[0111] The fermentation medium composition is: glucose 30 g / L, (NH4)2SO4 2 g / L, KH2PO4 2 g / L, MgSO4·7H2O 2 g / L, yeast extract 0.2 g / L, corn syrup 2 mL / L, FeSO4·7H2O 90 mg / L, MnSO4·7H2O 90 mg / L, and the rest is water, with a pH of 7.0-7.2.

[0112] The original strain E. coli UR11 and the modified strain original strain E. coli UR13 were verified by shake flask fermentation. The results are as follows Figure 3 Compared with the original strain E. coli UR11, the uridine production in the fermentation broth of E. coli UR13 increased from 8 g / L to 11 g / L, an increase of 37.5%.

[0113] Example 3: Production of uridine by fermentation in a fermenter using genetically engineered bacteria E. coli UR13:

[0114] Fermentation process: Take the -80℃ preserved strain and inoculate it on the activated slant, culture it at 37℃ for 12h, and transfer it to an eggplant-shaped bottle to continue culture for 12h. Take an appropriate amount of sterile water in an eggplant-shaped bottle, inoculate the bacterial suspension into the seed culture medium, stabilize the pH at around 7.0, maintain the temperature at 37℃, and the dissolved oxygen at 25-35%. Culture for 6h to obtain the seed liquid. Inoculate the seed liquid into the fresh fermentation medium at a 15% inoculation rate and start fermentation. During the fermentation process, control the pH to be stable at around 7.0, maintain the temperature at 37℃, and maintain the dissolved oxygen at 25-35%; when the glucose in the culture medium is consumed, add a glucose solution with a mass concentration of 80% (m / v) to maintain the glucose concentration in the fermentation medium at 0.1-5g / L; the fermentation cycle is 40h.

[0115] The slant culture medium was LB solid medium.

[0116] The composition of the seed culture medium was as follows: glucose 25 g / L, yeast extract 5 g / L, tryptone 3 g / L, KH2PO4 1.2 g / L, MgSO4·7H2O 0.5 g / L, FeSO4·7H2O 10 mg / L, MnSO4·7H2O 10 mg / L, V B1 、V B3 、V B5 、V B12 , V H 1 mg / L each, two drops of defoamer, the rest is water, pH is 7.0-7.2.

[0117] The fermentation medium composition was as follows: glucose 20 g / L, yeast extract 4 g / L, tryptone 5 g / L, citric acid 1 g / L, KH2PO4 2 g / L, MgSO4·7H2O 1 g / L, FeSO4·7H2O 90 mg / L, MnSO4·7H2O 90 mg / L, V B1 、V B3 、V B5 、V B12 , V H 2 mg / L each, 200 mg / L each of threonine, lysine, methionine, glutamine, and arginine, two drops of defoamer, and the rest is water, pH 7.0-7.2.

[0118] The original strain E. coli UR11 and the modified strain original strain E. coli UR13 were fermented in fermenter fermentation, and the results were as follows: Figure 4 Compared with the original strain E. coli UR11, the uridine yield in the fermentation broth of the E. coli UR13 strain increased from 40 g / L to 52 g / L, an increase of 30%, and the glycoside conversion rate increased from 15% to 20%, an increase of 33%.

[0119] The sequences used in the present invention are as follows:

[0120] The gene sequence of arcA described in SEQ ID NO.1 is:

[0121] ATGCAGACCCCGCACATTCTTATCGTTGAAGACGAGTTGGTAACACGCAACACGTTGAAAAGTATTTTCGAAGCGGAAGGCTATGATGTTTTCGAAGCGACAGATGGCGCGGAAATGCATCAGATCCTCTCTGAATATGACATCAACCTGGTGATCATGGATATCAATCTGCCGGGTAAGAACGGTCTTCTGTTAGCGCGTGAACTGCGCGAGCAGGCGAATGTTGCGTTGATGTTCCTGACTGGCCGTGACAACGAAGTCGATAAAATTCTCGGCCTCGAAATCGGTGCAGATGACTACATCACCAAACCGTTCAACCCGCGTGAACTGACGATTCGTGCACGCAACCTACTGTCCCGTACCATGAATCTGGGTACTGTCAGCGAAGAACGTCGTAGCGTTGAAAGCTACAAGTTCAATGGTTGGGAACTGGACATCAACAGCCGTTCGTTGATCGGCCCTGATGGCGAGCAGTACAAGCTGCCGCGCAGCGAGTTCCGCGCCATGCTTCACTTCTGTGAAAACCCAGGCAAAATTCAGTCCCGTGCTGAACTGCTGAAGAAAATGACCGGCCGTGAGCTGAAACCGCACGACCGTACTGTAGACGTGACGATCCGCCGTATTCGTAAACATTTCGAATCTACGCCGGATACGCCGGAAATCATCGCCACCATTCACGGTGAAGGTTATCGCTTCTGCGGTGATCTGGAAGATTAA

[0122] The gene sequence of the pyrB promoter described in SEQ ID NO.2 is:

[0123] TTAGCCGTTCGCTTTCACACTCCGCCCTATAAGTCGGATGAATGGAATAAAATGCATATCTGATTGCGTGAAAGTGAAAAAGGAAAAAGCAGGGAATGTCTGCAATTATTGATACCGAAGGACAGTTCCCCTGCAGAATCACATCAAATAAAAATGCATATACCTTGACTTTTAATTCAAATAAACCGTTTGCGCTGACAAAATATTGCATCAAATGCTTGCGCCGCTTCTGACGATGAGTATAATGCCGGACAATTTGCCGGGAGGATGTATGGTTCAGTGTGTTCGACATTTTGTCTTACCGCGTCTGAAAAAAGACGCTGGCCTGCCGTTTTTCTTCCCGTTGATCACCCATTCCCAGCCCCTCAATCGAGGGGCTTTTTTTTGCCCAGGCGTCAGGAGATAAAAG

[0124] The gene sequence of the pgi gene promoter described in SEQ ID NO.17 is:

[0125] CGACTGCGAACGCTTCTGGTGACAACCCAGGGGATTCAGCCCCTGTAGCCGATGATGAACGTGGCCAGCCGTTCAATCACCTCGGCGATGCACCCCCTCAGGTGTTATCACAGGACTGGCTCCTCCAACACCGTTACTTGGGCAACGCGCCTCTTCTGGCCTGCGCTAGCGCAGGTAGTACATTTATAAATAAAGGGTGAGCGGGGCGGTTGTCAACGATGGGGTCATGCGGATTTTTCATCCACTCCTGGCGGTCAGTAGTTCAGCTAATAAATGCTTCACTGCGCTAAGGGTTTACACTCAACATTACGCTAACGGCACTAAAACCATCACATTTTTCTGTGACTGGCGCTACAATCTTCCAAAGTCACAATTCTCAAAATCAGAAGAGTATTGCTA

[0126] Although the embodiments of the present invention are disclosed for illustrative purposes, those skilled in the art will appreciate that various substitutions, changes and modifications are possible without departing from the spirit and scope of the present invention and the appended claims. Therefore, the scope of the present invention is not limited to the contents disclosed in the embodiments.

Claims

1. A genetically engineered strain for increasing uridine production and conversion efficiency, characterized by: The genetically engineered strain is based on a genetically engineered bacterium E. coli UR11 (CN 108130306B) that produces uridine, but lacks the global transcriptional regulator encoding gene arcA and uses a uracil-responsive promoter P pyrB Replace the promoter of the phosphoglucose isomerase encoding gene pgi pgi , the genetically engineered bacteria E. coli UR13 was constructed.

2. The genetically engineered strain according to claim 1, characterized in that: The gene sequence of the global transcriptional regulator encoding gene arcA is SEQ ID NO.1, and the uracil-responsive promoter P pyrB The gene sequence is SEQ ID NO.2, the promoter of the phosphoglucose isomerase encoding gene pgi is P pgi The gene sequence is SEQ ID NO.

17.

3. The method for constructing a genetically engineered strain according to claim 1 or 2, wherein: The method is to gradually modify E. coli UR11 using CRISPR / Cas9-mediated gene editing technology, and the steps are as follows: (1) Knockout of arcA, the gene encoding the global transcriptional regulator; (2) Using uracil-responsive promoter P pyrB Replace the promoter of the phosphoglucose isomerase encoding gene pgi pgi ; The CRISPR / Cas9-mediated gene editing technology includes constructing a recombinant fragment and a pGRB plasmid, simultaneously transforming the pGRB plasmid and the recombinant fragment into electroporation competent cells containing pREDCas9, and performing a plasmid elimination step to obtain a recombinant genetically engineered strain.

4. The construction method according to claim 3, wherein: The construction of the pGRB plasmid includes: designing a target sequence, preparing a DNA fragment containing the target sequence, and recombining the DNA fragment containing the target sequence with a linearized vector fragment; preferably, the target sequence is 5'-NGG-3'; The construction of the recombinant fragment includes constructing a gene-integrated recombinant fragment or constructing a gene-knockout recombinant fragment; wherein the step of constructing the gene-integrated recombinant fragment includes: using the genome of the starting strain as a template, designing upstream and downstream homology arm primers according to the upstream and downstream sequences of the target gene insertion site, and designing primers according to the target genome, amplifying the target gene fragment, and then obtaining the recombinant fragment by PCR overlap technology.

5. Use of the genetically engineered strain according to claim 1 or 2 in the production of uridine.

6. A method for producing uridine by fermentation using the genetically engineered strain according to claim 1 or 2, characterized in that: The steps include: The genetically engineered strain is contacted with a fermentation medium and fermented to prepare uridine.

7. The method according to claim 6, characterized in that: The fermentation culture is shake flask fermentation or fermentation tank fermentation; During shake flask fermentation, the bacterial strain is activated and seed liquid is prepared, which is inoculated into a triangular flask containing fermentation medium at an inoculum rate of 10-15%, sealed with nine layers of gauze, and cultured at 37°C and 220 rpm with shaking. During the fermentation process, ammonia water is added to maintain the pH at 7.0-7.2; a glucose solution with a mass concentration of 60% is added to maintain the fermentation process; the fermentation cycle is 24 hours, and the product is obtained. During fermentation in a fermenter, the bacterial strain is activated and then a seed liquid is prepared, which is then added to a fresh fermentation medium at an inoculum rate of 15-20% to start fermentation. During the fermentation process, the pH is controlled to be stable at 7.0-7.2, the temperature is maintained at 37°C, and the dissolved oxygen is maintained between 25-35%. When the glucose in the culture medium is consumed, a glucose solution with a mass concentration of 80% is added to maintain the glucose concentration in the fermentation medium at 0.1-5 g / L. The fermentation cycle is 40 hours to obtain the product.

8. The method according to claim 7, wherein: The composition of the fermentation medium during shake flask fermentation is: glucose 20-40 g / L, (NH4)2SO4 1-3 g / L, KH2PO4 1-3 g / L, MgSO4·7H2O 1-2 g / L, yeast extract 0.1-0.3 g / L, corn steep liquor 1-2 mL / L, FeSO4·7H2O 80-100 mg / L, MnSO4·7H2O 80-100 mg / L, and the rest is water, with a pH of 7.0-7.

2.

9. The method according to claim 7, wherein: The fermentation medium composition of the fermentation tank is: glucose 15-25g / L, yeast extract 1-5g / L, tryptone 1-5g / L, sodium citrate 0.1-1g / L, KH2PO4 1-5 g / L, MgSO4·7H2O 0.1-1g / L, FeSO4·7H2O 80-100mg / L, MnSO4·7H2O 80-100mg / L, V B1 、V B3 、V B5 、V B12 , V H 0.5-2 mg / L each, 50-200 mg / L each of threonine, lysine, methionine, glutamine, and arginine, two drops of defoaming agent, and the rest is water, with a pH of 7.0-7.

2.

10. The method according to any one of claims 6 to 9, characterized in that: After 24 hours of shake flask fermentation, the uridine production in the fermentation broth of E. coli UR13 strain increased from 8 g / L to 11 g / L, a 37.5% increase compared with the original strain E. coli UR11. After 40 hours of fermentation in the fermentation tank, compared with the original strain E. coli UR11, the uridine yield in the fermentation broth of E. coli UR13 strain increased from 40 g / L to 52 g / L, an increase of 30%, and the glycoside conversion rate increased from 15% to 20%, an increase of 33%.

Citation Information

Patent Citations

  • Genetically engineered bacteria that produce high levels of uridine, their construction methods and applications

    CN108130306B